Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

A new vaccine that may delay cancer recurrence

A therapeutic cancer vaccine being co-developed by the Ludwig Institute for Cancer Research and the Australian biotech company CSL Limited successfully induced a comprehensive immune response in patients and appeared to delay cancer recurrence

21 Jul 2004

Cancer Research Technology grants exclusive license to Genentech to patent portfolio of an oncology target

Cancer Research Technology announced today that it has entered into a license agreement granting Genentech, Inc. exclusive worldwide rights to its patent portfolio covering an oncology target discovered in the Molecular Oncology Laboratory (Oxford) of Cancer Research UK.

21 Jul 2004

CancerVax may increase the survival of patients with advanced stage non-small-cell lung cancer

CancerVax Corporation has announced that its wholly owned subsidiaries, Tarcanta, Inc., and Tarcanta, Ltd. (Ireland), have obtained the exclusive rights to complete the clinical development of three specific active immunotherapeutic (SAI) product candidates that target the epidermal growth factor receptor (EGFR) signaling pathway for the treatment of cancer.

19 Jul 2004

New compound that is designed to overcome Gleevec resistance

One of the truly spectacular success stories in modern oncology is the development and implementation of Gleevec, a drug that virtually halts the progress of chronic myeloid leukemia. Yet for some patients who harbor particularly stubborn genetic mutations, Gleevec fails miserably.

17 Jul 2004

Stat5 protein is particularly plentiful in high histological grade human prostate cancer

Prostate cancer is much more likely to be aggressive if a key protein called Stat5 is found activated and in abundance in the cancer cells, report researchers from Georgetown University's Lombardi Comprehensive Cancer Center.

15 Jul 2004

Research may help predict risk for prostate cancer based on gene expression patterns

According to a study published in the July 15 issue of the Journal of Clinical Oncology, genes expressed in benign tissue adjacent to prostate cancer tissue are much more similar to those expressed in prostate cancer tissue than previously thought.

15 Jul 2004

Strategic analysis of the breast cancer therapeutics pipeline

Strategic partnerships between the pharmaceuticals industry and the biotechnology sector are making breast cancer therapeutics one of the most dynamic segments in the overall oncology market.

15 Jul 2004

Today's prostate cancer treatments are more aggressive and successful

In recent years, doctors have become more willing to treat prostate cancer more aggressively with radiation therapy, and as a result, more patients are being cured of their cancer

15 Jul 2004

New imaging agent will enable doctors to rapidly and accurately detect those hard-to-diagnose appendicitis cases

About half of the 700,000 annual cases of suspected appendicitis in the United States lack the usual symptoms – pain in the lower right abdomen, fever and a rising white blood cell count – making the decision to operate somewhat problematic.

7 Jul 2004

New information helps lung cancer patients better understand treatment

According to the American Cancer Society, nearly 175,000 Americans will learn they have lung cancer this year. Of these patients, it is estimated that nearly two-thirds of them will receive radiation therapy, either alone or in combination with other treatments.

7 Jul 2004

£18m to upgrade genetic laboratories in England

Six areas in England are to receive a share of £18m to upgrade genetic laboratories and help patients get genetic test results quicker.

5 Jul 2004

Best hospital in the United States for children

A U.S.News & World Report today ranked The Children's Hospital of Philadelphia the best hospital in the United States for children.

2 Jul 2004

Continued commercial development of research into DNA repair

Recent developments have greatly improved the understanding of the mechanisms used by cells to identify and repair breaks in DNA, and the potential for drugs that target DNA repair in the treatment of a range of human diseases including cancer.

28 Jun 2004

Kaposi sarcoma virus common in people who are HIV positive turns lymph vessel cells into a cancer

A virus turns lymph vessel cells into a cancer that affects people with weakened immune systems, according to research published today in Nature Genetics.

28 Jun 2004

System to treat patients over the internet via webcam

Physiotherapy is coming to a lounge room near you with a University of Queensland lecturer inventing a system to treat patients over the internet via webcam.

24 Jun 2004

Development of a blood test for the early detection of ovarian cancer

Leadership of U.S. Rep. Steve Israel, support from The Lynne Cohen Foundation, Row for a Cure and Totino Research Fund bring cutting edge research to Long Island.

22 Jun 2004

Genetically engineering viruses to carry a suicide gene into ovarian cancer cells

Genetically engineering viruses to carry a suicide gene into ovarian cancer cells could become a potent way to tackle the disease, a leading Cancer Research UK scientist reveals at a conference in Glasgow today (Tuesday).

22 Jun 2004

Cognitive decline can occur before chemotherapy treatment

In a series of studies in breast cancer patients, researchers at The University of Texas M. D. Anderson Cancer Center have confirmed the presence of “chemobrain” after chemotherapy treatment – but they also discovered that a significant portion of patients have cognitive declines even before chemotherapy.

21 Jun 2004

Research on the potential oral delivery of a current intravenous cancer drug using polymeric nano-delivery systems technology

Labopharm Inc. today announced that it has entered into an agreement with Debiopharm S.A. under which Debiopharm has engaged Labopharm to conduct research on the potential oral delivery of a current intravenous cancer drug using Labopharm’s proprietary polymeric nano-delivery systems technology (also referred to as micelles technology).

16 Jun 2004

Potential new strategy for blocking tumor growth

Targeting a master molecule that helps cancer cells survive when blood oxygen levels are low may offer a potentially powerful strategy for blocking tumor growth, say researchers at The University of Texas M. D. Anderson Cancer Center.

16 Jun 2004

Oncology News and Research

Further Reading

A new vaccine that may delay cancer recurrence

Cancer Research Technology grants exclusive license to Genentech to patent portfolio of an oncology target

CancerVax may increase the survival of patients with advanced stage non-small-cell lung cancer

New compound that is designed to overcome Gleevec resistance

Stat5 protein is particularly plentiful in high histological grade human prostate cancer

Research may help predict risk for prostate cancer based on gene expression patterns

Strategic analysis of the breast cancer therapeutics pipeline

Today's prostate cancer treatments are more aggressive and successful

New imaging agent will enable doctors to rapidly and accurately detect those hard-to-diagnose appendicitis cases

New information helps lung cancer patients better understand treatment

£18m to upgrade genetic laboratories in England

Best hospital in the United States for children

Continued commercial development of research into DNA repair

Kaposi sarcoma virus common in people who are HIV positive turns lymph vessel cells into a cancer

System to treat patients over the internet via webcam

Development of a blood test for the early detection of ovarian cancer

Genetically engineering viruses to carry a suicide gene into ovarian cancer cells

Cognitive decline can occur before chemotherapy treatment

Research on the potential oral delivery of a current intravenous cancer drug using polymeric nano-delivery systems technology

Potential new strategy for blocking tumor growth

Cancer Research eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News